Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab in Combination With Chemoradiation for Patients With Stage II-IVB Nasopharyngeal Carcinoma
NCT03267498Phase 2Completed
- Start
- Feb 2018
- Primary completion
- Oct 2024
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of nivolumab in nasopharyngeal carcinoma (NPC). Started Feb 2018; status: completed.
02
Drugs
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT03267498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03267498.